Join the Breast Cancer group to help and get support from people like you.
Breast Cancer News (Page 5)
Related terms: Breast Cancer, inflammatory, Cancer, Breast, Carcinoma, Ductal, Carcinoma, Lobular, Ductal Carcinoma in Situ (DCIS), Ductal Carcinoma in Situ, DCIS
Stressors Affect Systemic Inflammation, Tumor Aggressiveness in Breast Cancer
THURSDAY, Feb. 27, 2025 – For women with breast cancer, stressors are associated with deleterious alterations to the systemic and tumor immune environment, according to a study published online Feb....
Breast Cancer Incidence Rates Vary by Region in U.S. Women Younger Than 40
THURSDAY, Feb. 27, 2025 – For U.S. women younger than 40 years, breast cancer incidence rates vary by geography, according to a study published online Feb. 12 in Cancer Causes & Control. Rebecca D....
Young Women's Locale Plays Role In Breast Cancer Risk
WEDNESDAY, Feb. 26, 2025 – Where a young American woman lives could play a role in her risk for breast cancer, a new study suggests. In fact, the breast cancer risk associated with a young woman’s l...
2.3 Million New Female Breast Cancer Cases Seen Globally in 2022
MONDAY, Feb. 24, 2025 – In 2022, there were 2.3 million new breast cancer cases and 670,000 deaths from female breast cancer globally, according to a study published online Feb. 24 in Nature...
Breast Cancer A Killer In Poor Countries, Report Says
TUESDAY, Feb. 25, 2025 – Breast cancer deaths are expected to increase during the next quarter-century, largely impacting the world’s poorest nations, a new international study says. About 1.1 m...
Women Of Color Receive Slower Response To A Bad Mammogram
WEDNESDAY, Feb. 19, 2025 – Women of color are less likely to receive prompt follow-up testing after abnormal mammogram results, a new study has found. Minority women are less likely than white women...
Minority Groups Less Likely to Receive Diagnostic Services After Abnormal Mammogram
WEDNESDAY, Feb. 19, 2025 – For patients after screening mammography, onsite availability of most diagnostic services is similar across race and ethnicity groups, but minority groups are less likely...
What Cancer Screenings Do You Need? A Quick Guide
SATURDAY, Feb. 15, 2025 – Cancer screenings can save lives by detecting cancer early, when treatment is most effective. With an estimated 2 million new cancer cases expected in 2025, regular...
American Cancer Society Calls for Restoration of Key CDC, FDA Data
FRIDAY, Feb. 14, 2025 – With certain government data currently being withheld, removed, or restored but partially redacted on the websites of the U.S. Centers for Disease Control and Prevention and...
AI Contributes to Early Detection of Clinically Relevant Breast Cancer
THURSDAY, Feb. 13, 2025 – Artificial intelligence (AI) contributes to early detection of clinically relevant breast cancer, according to a study published online Feb. 3 in The Lancet Digital Health....
Breast Cancer: Fear of Recurrence Can Haunt Women for Years
MONDAY, Feb. 10, 2025 – A survey of hundreds of breast cancer survivors finds that tumor recurrence fear can wreak havoc on a woman's emotions. “Cancer is all around us. Everything is a trigger," o...
Pre-Op Immunotherapy May Help Treat Aggressive Breast Cancers
FRIDAY, Feb. 7, 2025 – Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a new phase 3 trial finds. The study involved patients with...
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
THURSDAY, Feb. 6, 2025 – For patients with high-risk, early-stage estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative primary breast cancer (BC), adding...
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
MONDAY, Feb. 3, 2025 – The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone receptor ...
FDA Approves Datroway for HR-Positive, HER2-Negative Breast Cancer
FRIDAY, Jan. 31, 2025 -- The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with unresectable or metastatic, hormone receptor (HR)-positive, ...
Further information
Related condition support groups
Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer - Male, Cancer
Related drug support groups
methotrexate, fluorouracil, anastrozole, letrozole, Keytruda, Herceptin, Arimidex, doxorubicin, Femara, trastuzumab, tamoxifen, Ibrance, docetaxel